4//SEC Filing
Romano Sarah 4
Accession 0001104659-23-001230
CIK 0001604191other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:01 AM ET
Size
5.1 KB
Accession
0001104659-23-001230
Insider Transaction Report
Form 4
Romano Sarah
Chief Financial Officer
Transactions
- Award
Common Stock
2023-01-03+150,000→ 150,000 total
Footnotes (2)
- [F1]On January 3, 2023, the Reporting Person was granted 150,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning March 31, 2023.
- [F2]Includes unvested RSUs.
Documents
Issuer
First Wave BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001697536
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 9:01 AM ET
- Size
- 5.1 KB